PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 180 filers reported holding PTC THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,381,420 | -40.5% | 61,643 | +8.0% | 0.01% | -37.5% |
Q2 2023 | $2,321,606 | -8.7% | 57,084 | +8.8% | 0.01% | -11.1% |
Q1 2023 | $2,542,470 | +12.7% | 52,487 | -11.2% | 0.01% | 0.0% |
Q4 2022 | $2,256,610 | -3.4% | 59,120 | +27.1% | 0.01% | 0.0% |
Q3 2022 | $2,335,000 | -17.1% | 46,517 | -33.8% | 0.01% | -18.2% |
Q2 2022 | $2,815,000 | +14.8% | 70,266 | +6.9% | 0.01% | +37.5% |
Q1 2022 | $2,452,000 | -12.3% | 65,727 | -6.4% | 0.01% | 0.0% |
Q4 2021 | $2,796,000 | +5.6% | 70,198 | -1.3% | 0.01% | 0.0% |
Q3 2021 | $2,647,000 | -3.7% | 71,138 | +9.4% | 0.01% | -11.1% |
Q2 2021 | $2,748,000 | +29.7% | 65,002 | +45.4% | 0.01% | +28.6% |
Q1 2021 | $2,118,000 | -24.1% | 44,721 | -2.1% | 0.01% | -30.0% |
Q4 2020 | $2,789,000 | +22.5% | 45,696 | -6.1% | 0.01% | +11.1% |
Q3 2020 | $2,276,000 | -2.0% | 48,681 | +6.4% | 0.01% | -10.0% |
Q2 2020 | $2,322,000 | +1.8% | 45,763 | -10.4% | 0.01% | -9.1% |
Q1 2020 | $2,280,000 | -7.1% | 51,103 | 0.0% | 0.01% | +22.2% |
Q4 2019 | $2,454,000 | +35.7% | 51,103 | -4.5% | 0.01% | +28.6% |
Q3 2019 | $1,809,000 | – | 53,500 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Burrage Capital Management LLC | 161,083 | $9,831,000 | 7.49% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 333,000 | $20,323,000 | 5.55% |
RTW INVESTMENTS, LP | 4,221,836 | $257,659,000 | 4.32% |
GEORGE KAISER FAMILY FOUNDATION | 90,011 | $10,766,000 | 2.85% |
SECTORAL ASSET MANAGEMENT INC | 603,978 | $36,861,000 | 2.60% |
Redwood Investments, LLC | 364,837 | $22,266,000 | 1.90% |
ARMISTICE CAPITAL, LLC | 716,000 | $43,697,000 | 1.49% |
CM Management, LLC | 25,000 | $1,526,000 | 1.42% |
Third Security, LLC | 237,015 | $14,465,000 | 1.32% |
Sofinnova Investments, Inc. | 316,478 | $19,315,000 | 1.15% |